Gleolan: payments to doctors
Payments that named Gleolan as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1M
- Providers
- 121
- Transactions
- 176
- Average per transaction
- $5,802
The per-transaction average — $5,802 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 121 providers the average total is $8,439, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| NX Development Corp. | $922,870 | 90.4% |
| Medexus Pharma, Inc. | $98,219 | 9.6% |